Indefinite Delivery Contract 75A50118D00036

Award Date 9/27/18
Last Date to Order 12/31/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Cost Sharing
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed

This Indefinite Delivery Contract (IDC) with ID 75A50118D00036 was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Genentech Inc., a for-profit manufacturer, on September 27, 2018. The contract has a ceiling value of $611,540,628.30 and a period of performance through December 31, 2027.

The contract provides funding for Genentech to conduct activities related to the antiviral drug baloxavir marboxil under a base period task order. This supports the ASPR's preparedness and response efforts, though the specific details of the procured products and services are not provided. The contract was awarded without any set-asides and is a single-award IDC, meaning Genentech is the sole awardee. No additional information on related task orders or price lists was included in the provided materials.

Generated 1/11/25, 9:04 AM